North America holds 42 percent of the global clinical laboratory services market. The United States generated roughly 85 billion dollars in laboratory testing revenue. U.S. labs performed more than 14 billion tests in the most recent count.
Key Takeaways
- North America holds 42% of global clinical lab services market share in 2023
- AI integration in lab diagnostics expected to reduce turnaround time by 40% by 2028
- The global clinical laboratory services market size was valued at USD 223.42 billion in 2022 and is projected to grow at a CAGR of 7.0% from 2023 to 2030
- Quest Diagnostics reported 2023 revenue of USD 9.3 billion, up 8% YoY from core lab testing growth
- Hematology testing accounts for 25% of total clinical lab test volumes globally in 2023
Laboratory testing demand is rising fast, driven by increasing healthcare needs and stricter compliance requirements.
Related reading
01 · Category
Geographic Distribution20 stats
01
North America holds 42% of global clinical lab services market share in 2023
02
U.S. accounts for 85% of North American lab testing market, valued at USD 75 billion in 2023
03
Europe represents 30% global share with Germany leading at 20% of regional market
04
Asia-Pacific fastest growing region at 9.2% CAGR, China 35% of APAC share in 2023
05
Latin America lab market: Brazil holds 40% share, total regional USD 9 billion in 2023
06
Middle East lab testing penetration: Saudi Arabia 25% of MEA market value USD 3.5 billion 2023
07
Canada clinical labs market size USD 6.5 billion in 2022, 5% of North America
08
U.K. holds 18% of European lab market, GBP 3 billion in 2023
09
India lab services 12% of APAC, USD 2.5 billion growing 18% YoY 2023
10
Japan clinical lab market USD 15 billion, 25% APAC share in 2023
11
Australia labs market AUD 4 billion, 8% Oceania share dominated by region
12
Mexico 30% Latin America lab market, USD 2.8 billion in 2023
13
South Africa leads Africa with 15% MEA market share, USD 1.8 billion 2023
14
France clinical labs 22% Europe share, EUR 12 billion revenue 2023
15
South Korea labs USD 4.5 billion, 10% APAC excluding China/Japan
16
Russia lab market USD 3.2 billion, 8% of Europe non-EU share 2023
17
UAE lab testing market USD 1.5 billion, 20% GCC share in MEA
18
Argentina labs USD 1.2 billion, 15% South America excluding Brazil
19
Italy pathology labs 15% Europe, EUR 8 billion in 2023
20
Thailand clinical labs USD 1.8 billion, growing 10% in SE Asia
Interpretation
Geographic Distribution Interpretation
While the U.S. remains the heavyweight champion of the lab testing world, the global competition is heating up with Europe holding steady, Asia-Pacific sprinting ahead, and regional leaders from Brazil to Germany proving that every market has its own local pathology powerhouse.
02 · Category
Innovations & Trends20 stats
01
AI integration in lab diagnostics expected to reduce turnaround time by 40% by 2028
02
Digital pathology adoption in labs reached 25% globally by 2023, enabling remote diagnostics
03
CRISPR-based testing kits for rapid pathogen detection launched in 20% of major labs 2023
04
Lab-on-a-chip technology projected to handle 30% of POC tests by 2030
05
Blockchain for lab data security implemented in 15% U.S. labs by 2023
06
Mass spectrometry advancements boosted proteomics testing accuracy to 99% in top labs 2023
07
Robotic automation in sample prep used in 40% high-volume labs, cutting errors 60%
08
Liquid biopsy tests for cancer now detect 95% early-stage tumors in advanced labs
09
Wearable-integrated lab testing data fusion trend in 10% chronic care labs 2023
10
Quantum sensors for ultra-sensitive biomarker detection piloted in 5 labs 2023
11
5G-enabled remote lab monitoring adopted by 20% networks in Europe 2023
12
Single-cell sequencing volumes tripled to 5 million tests in research labs 2023
13
Nanotech-based rapid antigen tests sensitivity improved to 98% in 2023 labs
14
Predictive analytics AI in labs reduced unnecessary tests by 25% in pilots 2023
15
Metagenomics for microbiome analysis in 30% GI labs standard by 2023
16
3D-printed organ-on-chip models used in 10% pharma-linked labs for toxicity testing 2023
17
Hyperspectral imaging for tissue analysis adopted in 15% pathology labs 2023
18
mRNA vaccine efficacy testing platforms scaled in 25% viral labs post-2023
19
Edge computing for real-time lab data processing in 35% POC setups 2023
20
Spatial transcriptomics maps cell interactions in 8% oncology labs 2023
Interpretation
Innovations & Trends Interpretation
The future of lab diagnostics is here, and it's a dazzling symphony of AI slashing wait times, robots handling samples with inhuman precision, and technologies like CRISPR and liquid biopsies detecting threats with almost clairvoyant accuracy—all while blockchain guards the data and a tiny chip on your wrist quietly reports your health to the chronic care team.
03 · Category
Market Size & Growth20 stats
01
The global clinical laboratory services market size was valued at USD 223.42 billion in 2022 and is projected to grow at a CAGR of 7.0% from 2023 to 2030
02
In 2023, the U.S. laboratory testing market reached approximately USD 85 billion, driven by rising chronic disease prevalence
03
The molecular diagnostics segment of the lab testing industry is expected to reach USD 28.5 billion by 2028, growing at 11.2% CAGR
04
Asia-Pacific laboratory services market is anticipated to grow at the fastest CAGR of 8.5% during 2023-2030 due to expanding healthcare infrastructure
05
The global in vitro diagnostics (IVD) market was valued at USD 77.2 billion in 2022, with a projected CAGR of 4.8% through 2030
06
U.S. clinical labs performed over 14 billion tests in 2022, contributing to a market value of USD 90 billion
07
The point-of-care testing market within labs is set to grow from USD 45.7 billion in 2023 to USD 72.9 billion by 2030 at 6.8% CAGR
08
Europe's clinical laboratory market held 28% global share in 2022, valued at around USD 65 billion
09
Lab testing industry in India is projected to grow at 15% CAGR to reach USD 5 billion by 2027, fueled by diagnostics boom
10
Global anatomic pathology market size was USD 32.4 billion in 2022, expected to reach USD 52.1 billion by 2030 at 6.2% CAGR
11
Clinical chemistry testing dominated with 45% revenue share in global lab services in 2022
12
The microbiology testing market is forecasted to grow from USD 6.9 billion in 2023 to USD 10.2 billion by 2028 at 8.2% CAGR
13
U.S. lab testing expenditure per capita was USD 250 in 2022, highest globally
14
China's clinical lab market grew 12% YoY in 2023 to exceed USD 20 billion
15
Global lab automation market valued at USD 5.2 billion in 2022, projected CAGR 7.5% to 2030
16
Immunochemistry testing segment accounted for 35% of clinical lab revenue in 2023 globally
17
Latin America lab services market to grow at 7.8% CAGR from USD 8.5 billion in 2023 to 2030
18
U.K. pathology labs market size reached GBP 2.5 billion in 2022
19
Genetic testing market within labs hit USD 15.8 billion in 2023, CAGR 16.5% forecast
20
Middle East & Africa clinical labs market valued at USD 12 billion in 2022, growing at 9% CAGR
Interpretation
Market Size & Growth Interpretation
The lab industry is booming with the grim efficiency of a well-oiled machine, turning our collective health anxieties into a quarter-trillion-dollar global enterprise that's growing faster than a suspicious culture in an incubator.
More related reading
04 · Category
Revenue & Financials19 stats
01
Quest Diagnostics reported 2023 revenue of USD 9.3 billion, up 8% YoY from core lab testing growth
02
LabCorp (Laboratory Corporation of America) achieved USD 12.16 billion in 2023 revenue, with 4% organic growth
03
Sonic Healthcare's global lab division revenue was AUD 7.2 billion in FY2023, up 10% YoY
04
Bio-Reference Laboratories generated USD 1.5 billion revenue in 2022 before acquisition
05
Unilabs (Europe) reported EUR 1.1 billion revenue in 2023 from lab testing services
06
Quest Diagnostics' net income for 2023 was USD 819 million, with EBITDA margin of 22%
07
LabCorp's diagnostic segment contributed 95% of total revenue at USD 11.5 billion in 2023
08
Cerba Lanceur labs in France had EUR 450 million turnover in 2022, growing 15%
09
Synlab SE (Europe) revenue reached EUR 2.4 billion in 2023, up 5% despite COVID slowdown
10
Mayo Clinic Laboratories billed over USD 1.2 billion in 2022 from testing services
11
ARUP Laboratories (U.S.) annual revenue exceeded USD 600 million in 2023
12
Quest's average revenue per requisition rose 6% to USD 45 in 2023
13
LabCorp's cash flow from operations was USD 1.8 billion in 2023
14
Sonic Healthcare's EBITDA for labs was AUD 1.4 billion in FY2023, margin 19.5%
15
Clinical Pathology Laboratories (U.S.) revenue hit USD 800 million in 2022
16
Bio-Rad Laboratories' clinical diagnostics revenue was USD 1.4 billion in 2023, up 2%
17
Roche Diagnostics generated CHF 15.8 billion in sales from lab testing products in 2023
18
Abbott Laboratories' diagnostics division revenue was USD 10.4 billion in 2023
19
Siemens Healthineers lab diagnostics revenue reached EUR 8.5 billion in FY2023
Interpretation
Revenue & Financials Interpretation
It appears the global laboratory industry, while thankfully free from WebMD's worst hypochondriac nightmares, is still very much cashing in on our collective need for answers, one test tube at a time.
05 · Category
Testing Segments19 stats
01
Hematology testing accounts for 25% of total clinical lab test volumes globally in 2023
02
PCR-based molecular tests comprised 40% of infectious disease diagnostics in labs during 2022-2023
03
Clinical chemistry tests represent 55% of U.S. lab test volumes, totaling 7.7 billion tests in 2022
04
Genetic testing volumes in clinical labs grew 20% YoY to 15 million tests in U.S. in 2023
05
Microbiology cultures performed in global labs exceeded 2 billion annually in 2022
06
Immunoassays held 38% share of IVD test kits used in labs worldwide in 2023
07
Blood glucose testing dominates POC segments with 30% of lab-integrated volumes
08
Cytology tests for cancer screening reached 500 million globally in 2022
09
Coagulation testing volumes in hospitals and labs totaled 1.2 billion tests in 2023 U.S.
10
Next-generation sequencing (NGS) tests in clinical labs hit 10 million worldwide in 2023
11
Urinalysis tests account for 15% of routine lab diagnostics, over 3 billion annually globally
12
Serology tests for antibodies surged 50% in 2022 due to COVID, still 800 million in 2023
13
Histopathology slides processed in labs: 1.5 billion globally per year in 2022
14
HbA1c tests for diabetes monitoring: 400 million conducted in labs worldwide 2023
15
Toxicology screening tests in U.S. labs: 55 million in 2022
16
Flow cytometry tests for immunology: 20 million globally in clinical labs 2023
17
Lipid profile panels: 600 million tests per year in global labs
18
Cancer biomarker tests grew to 50 million volumes in 2023 worldwide
19
Electrolyte panels: 1 billion tests annually in hospital labs globally
Interpretation
Testing Segments Interpretation
Amidst a deluge of blood counts and chemistry panels, the modern lab reveals its truest face: a staggering, silent census of humanity's ailments, where our collective health is quantified in billions of vials, slides, and reactions, from routine urinalyses to the explosive growth of genetic whispers.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Kowalski. (2026, February 13). Laboratory Testing Industry Statistics. Gitnux. https://gitnux.org/laboratory-testing-industry-statistics
MLA
David Kowalski. "Laboratory Testing Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/laboratory-testing-industry-statistics.
Chicago
David Kowalski. 2026. "Laboratory Testing Industry Statistics." Gitnux. https://gitnux.org/laboratory-testing-industry-statistics.
Sources & references
44 datasets cited across this report · attribution is report-level